Premium
Down's syndrome and mixed acute leukemia in infants
Author(s) -
Penchansky Lila,
Kaplan Sandra S.,
Stolc Viktor,
Krause John R.
Publication year - 1991
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19910715)68:2<414::aid-cncr2820680233>3.0.co;2-g
Subject(s) - terminal deoxynucleotidyl transferase , immunophenotyping , medicine , leukemia , myeloid , immunology , population , acute leukemia , myeloid leukemia , monoclonal , monoclonal antibody , antibody , antigen , immunohistochemistry , environmental health , tunel assay
The routine use of panels of monoclonal antibodies has been complementary to the French–American–British (FAB) leukemia classification, and has unmasked the occurrence of mixed acute leukemia (myeloid–lymphoid). It is widely accepted that children with Down's syndrome (DS) have a high incidence of acute leukemia. There is an extensive body of literature emphasizing the cytogenetic findings in these children. However, information as to the immunophenotype is often limited to the lymphoid surface determinants. The authors report two children with DS whose leukemic blasts were studied with a panel of 17 monoclonal antibodies (myeloid, lymphoid, and megakaryocytic) by flow cytometric examination and were classified as biphenotypic acute leukemia. The blast population coexpressed myeloid and T‐cell surface markers. The lymphoid origin was ruled out on the basis of negative terminal deoxynucleotidyl transferase and molecular analysis demonstrating germline configuration for the JH and βTCR genes.